Literature DB >> 1363505

Effect of BRL-35135 on LTB4-induced guinea pig eosinophil chemotaxis.

T Sugasawa1, S Morooka.   

Abstract

The effect of an atypical beta-adrenoceptor agonist, BRL-35135 on leukotriene B4-induced-guinea pig eosinophil chemotaxis was studied. BRL-35135 and SC-41930 (leukotriene B4-antagonist) inhibited the chemotaxis in a concentration-dependent manner (IC50 = 9.0 x 10(-6) and 2.6 x 10(-7) M, respectively). However, isoproterenol, fenoterol and another atypical beta-agonist, BRL-37344 had no effects. The inhibitory effect of BRL-35135 was not affected by (+/-)-propranolol (10(-4) M). In contrast, the nonselective beta-adrenoceptor antagonist, (-)-alprenolol (10(-4) M) dextrally shifted the inhibitory curve of BRL-35135. The response to BRL-35135 was antagonized in a competitive manner by (-)-alprenolol, with the slope of the Schild plot close to unity, and a pA2 value of 5.62. These findings suggest that guinea pig eosinophils possess an "atypical receptor", which differs from either beta 1-, beta 2- or atypical beta-adrenoceptor on guinea pig ileum, and through which eosinophil chemotaxis can be modulated by BRL-35135.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1363505     DOI: 10.1007/bf02028114

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  22 in total

1.  Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B4 antagonist U-75,302.

Authors:  B M Taylor; C I Czuk; M N Brunden; D G Wishka; J Morris; F F Sun
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1989

2.  In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and its w-oxidation products.

Authors:  B M Czarnetzki; R Mertensmeier
Journal:  Prostaglandins       Date:  1985-07

3.  Molecular characterization of the human beta 3-adrenergic receptor.

Authors:  L J Emorine; S Marullo; M M Briend-Sutren; G Patey; K Tate; C Delavier-Klutchko; A D Strosberg
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

4.  A new simplified single-filter assay for 'in vitro' evaluation of chemotaxis of 51Cr-labeled polymorphonuclear leukocytes.

Authors:  F Capsoni; F Minonzio; A M Ongari; C Zanussi
Journal:  J Immunol Methods       Date:  1989-06-02       Impact factor: 2.303

5.  Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs.

Authors:  J R Arch; A T Ainsworth; M A Cawthorne; V Piercy; M V Sennitt; V E Thody; C Wilson; S Wilson
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

6.  SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.

Authors:  B S Tsai; D Villani-Price; R H Keith; J M Zemaitis; R F Bauer; R Leonard; S W Djuric; R L Shone
Journal:  Prostaglandins       Date:  1989-12

7.  Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.

Authors:  T Fukuda; S L Dunnette; C E Reed; S J Ackerman; M S Peters; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1985-11

8.  A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism.

Authors:  R A Bond; D E Clarke
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

9.  Evidence for the existence of 'atypical' beta-adrenoceptors (beta 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro.

Authors:  D P McLaughlin; A MacDonald
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

10.  Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.

Authors:  D R Blue; R A Bond; N Adham; R Delmendo; A D Michel; R M Eglen; R L Whiting; D E Clarke
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

View more
  1 in total

1.  Pharmacological profile of a novel, orally active leukotriene B4 antagonist, SM-15178.

Authors:  N Ohmi; C Tani; K Yamada; M Fukui
Journal:  Inflammation       Date:  1994-04       Impact factor: 4.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.